JOIN US IN |
CALL FOR ABSTRACTS Deadline: July 6th, 2025 |
• Preleukemic hematopoiesis and clonal diversity
• Preleukemic conditions and predisposition
• Epigenetics
• MDS / Secondary leukemia
• Immune targeting
• Therapeutic targeting
About the Conference:
The seventh bi-annual ESH conference in this series will offer discussions on the latest developments and emerging insights in the fascinating biology and rapidly changing clinical landscape of AML.
Continuing Medical Education (CME) credit points will be awarded to physicians for the time they will spend at the meeting improving their knowledge and skills. ESH is a provider of the European Hematology CME system.
This meeting will be valuable to you if you are looking for:
- A cutting-edge scientific program – from basic science to clinical and therapeutic applications and perspectives
- Multiple opportunities for scientific interaction with an international faculty of distinguished experts
- An emphasis on critical discussion
The meeting will provide clinicians and scientists with state-of-the-art recommendations regarding patient care and insight in controversies in the field.
The meeting will be of interest to:
- Ph-students, post docs, junior and senior biologists and practicing clinicians (MD, PhD, MD-PhD), hematologists and oncologists in training
- Residents and biologists still in training
The program will include:
Plenary Sessions - Simultaneous Meet the Expert Sessions
Panel Discussions - Poster Walks - Ample time for in-depth discussion
With the support of*:
Emerald Conference Partner
*******
Supporting Partner
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.